-
1
-
-
0024976004
-
Cyclosporine
-
Kahan BD. Cyclosporine. N Engl J Med 1989; 321:1725
-
(1989)
N Engl J Med
, vol.321
, pp. 1725
-
-
Kahan, B.D.1
-
2
-
-
0027226147
-
Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation
-
Lindholm A, Kahan BD. Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 1993; 54:205
-
(1993)
Clin Pharmacol Ther
, vol.54
, pp. 205
-
-
Lindholm, A.1
Kahan, B.D.2
-
3
-
-
0036580336
-
How pharmacokinetic and pharmacodynamic drug monitoring can improve outcome in solid organ transplant recipients
-
Klupp J, Holt DW, van Gelder T. How pharmacokinetic and pharmacodynamic drug monitoring can improve outcome in solid organ transplant recipients. Transpl Immunol 2002; 9:211
-
(2002)
Transpl Immunol
, vol.9
, pp. 211
-
-
Klupp, J.1
Holt, D.W.2
Van Gelder, T.3
-
4
-
-
0028909913
-
Cyclosporine trough levels, acute rejection, and renal dysfunction after heart transplantation
-
Cantarovich M, Fitchett D, Latter DA. Cyclosporine trough levels, acute rejection, and renal dysfunction after heart transplantation. Transplantation 1995; 59:444
-
(1995)
Transplantation
, vol.59
, pp. 444
-
-
Cantarovich, M.1
Fitchett, D.2
Latter, D.A.3
-
5
-
-
0033565808
-
Neoral monitoring by simplified sparse sampling area under the concentration-time curve: Its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation
-
Mahalati K, Belitsky P, Sketris I, West K, Panek R. Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation. Transplantation 1999; 68:55
-
(1999)
Transplantation
, vol.68
, pp. 55
-
-
Mahalati, K.1
Belitsky, P.2
Sketris, I.3
West, K.4
Panek, R.5
-
6
-
-
0036766650
-
Adequate early cyclosporin exposure is critical to prevent renal allograft rejection: Patients monitored by absorption profiling
-
Clase CM, Mahalati K, Kiberd BA, Lawen JG, West KA, Fraser AD, et al. Adequate early cyclosporin exposure is critical to prevent renal allograft rejection: patients monitored by absorption profiling. Am J Transplant 2002; 2:789
-
(2002)
Am J Transplant
, vol.2
, pp. 789
-
-
Clase, C.M.1
Mahalati, K.2
Kiberd, B.A.3
Lawen, J.G.4
West, K.A.5
Fraser, A.D.6
-
7
-
-
0028063546
-
The pharmacokinetics of Sandimmun Neoral: A new oral formulation of cyclosporine
-
Holt DW, Mueller EA, Kovarik JM, van Bree JB, Kutz K. The pharmacokinetics of Sandimmun Neoral: a new oral formulation of cyclosporine. Transplant Proc 1994; 26:2935
-
(1994)
Transplant Proc
, vol.26
, pp. 2935
-
-
Holt, D.W.1
Mueller, E.A.2
Kovarik, J.M.3
Van Bree, J.B.4
Kutz, K.5
-
9
-
-
0034743294
-
C2 monitoring strategy for optimising cyclosporin immunosuppression from the Neoral formulation
-
Levy GA. C2 monitoring strategy for optimising cyclosporin immunosuppression from the Neoral formulation. BioDrugs 2001; 15:279
-
(2001)
BioDrugs
, vol.15
, pp. 279
-
-
Levy, G.A.1
-
10
-
-
0035086066
-
Approaching the therapeutic window for cyclosporine in kidney transplantation: A prospective study
-
Mahalati K, Belitsky P, West K, Kiberd B, Fraser A, Sketris I, et al. Approaching the therapeutic window for cyclosporine in kidney transplantation: a prospective study. J Am Soc Nephrol 2001; 12:828
-
(2001)
J Am Soc Nephrol
, vol.12
, pp. 828
-
-
Mahalati, K.1
Belitsky, P.2
West, K.3
Kiberd, B.4
Fraser, A.5
Sketris, I.6
-
11
-
-
0037093525
-
Patient management by Neoral C(2) monitoring: An international consensus statement
-
Levy G, Thervet E, Lake J, Uchida K. Patient management by Neoral C(2) monitoring: an international consensus statement. Transplantation 2002; 73:812
-
(2002)
Transplantation
, vol.73
, pp. 812
-
-
Levy, G.1
Thervet, E.2
Lake, J.3
Uchida, K.4
-
12
-
-
0037181448
-
Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2)
-
Levy G, Burra P, Cavallari A, Duvoux C, Lake J, Mayer AD, et al. Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2). Transplantation 2002; 73:953
-
(2002)
Transplantation
, vol.73
, pp. 953
-
-
Levy, G.1
Burra, P.2
Cavallari, A.3
Duvoux, C.4
Lake, J.5
Mayer, A.D.6
-
13
-
-
0012007095
-
Monitoring of 2-hour Neoral absorption in renal transplantation (MO2ART): Interim analysis shows low incidence of acute rejection in the early post-graft period
-
The MO2ART study group. Abstract no. 1037.
-
Pfeffer P, Stefoni S, Agost Carreno C, Thervet E, Fornairon S, Keown P. Monitoring of 2-hour Neoral absorption in renal transplantation (MO2ART): interim analysis shows low incidence of acute rejection in the early post-graft period. The MO2ART study group. Abstract no. 1037. Am J Transplant 2002; 2:399
-
(2002)
Am J Transplant
, vol.2
, pp. 399
-
-
Pfeffer, P.1
Stefoni, S.2
Agost Carreno, C.3
Thervet, E.4
Fornairon, S.5
Keown, P.6
-
14
-
-
0009944063
-
Excellent renal tolerability of Neoral C-2 h monitoring in the de novo kidney transplantation: Initial results of the MO2ART trial
-
The MO2ART study group. Abstract no. 1038
-
Buchler M, Chadban S, Jost L, Rodriguez A, Beauregard L, Balshaw R. Excellent renal tolerability of Neoral C-2 h monitoring in the de novo kidney transplantation: initial results of the MO2ART trial. The MO2ART study group. Abstract no. 1038. Am J Transplant 2002; 2:399
-
(2002)
Am J Transplant
, vol.2
, pp. 399
-
-
Buchler, M.1
Chadban, S.2
Jost, L.3
Rodriguez, A.4
Beauregard, L.5
Balshaw, R.6
-
15
-
-
0033611084
-
Clinical benefit of Neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients
-
Cantarovich M, Elstein E, de Varennes B, Barkun JS. Clinical benefit of Neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients. Transplantation 1999; 68:1839
-
(1999)
Transplantation
, vol.68
, pp. 1839
-
-
Cantarovich, M.1
Elstein, E.2
De Varennes, B.3
Barkun, J.S.4
-
16
-
-
0037093506
-
Clinical validation studies of Neoral C(2) monitoring: A review
-
Nashan B, Cole E, Levy G, Thervet E. Clinical validation studies of Neoral C(2) monitoring: a review. Transplantation 2002; 73:S3
-
(2002)
Transplantation
, vol.73
-
-
Nashan, B.1
Cole, E.2
Levy, G.3
Thervet, E.4
-
17
-
-
0037006627
-
Efficacy and safety of tacrolimus compared with cyclosporin micro-emulsion in renal transplantation: A randomised multicentre study
-
Margreiter R. Efficacy and safety of tacrolimus compared with cyclosporin micro-emulsion in renal transplantation: a randomised multicentre study. Lancet 2002; 359:741
-
(2002)
Lancet
, vol.359
, pp. 741
-
-
Margreiter, R.1
-
18
-
-
0037068958
-
Tacrolimus versus micro-emulsified cyclosporin in liver transplantation: The TMC randomised controlled trial
-
O'Grady JG, Burroughs A, Hardy P, Elbourne D, Truesdale A. Tacrolimus versus micro-emulsified cyclosporin in liver transplantation: the TMC randomised controlled trial. Lancet 2002; 360:1119
-
(2002)
Lancet
, vol.360
, pp. 1119
-
-
O'Grady, J.G.1
Burroughs, A.2
Hardy, P.3
Elbourne, D.4
Truesdale, A.5
-
19
-
-
0033959965
-
Impact of cyclosporin a pharmacokinetics on the presence of side effects in pediatric renal transplantation
-
David-Neto E, Lemos FB, Furusawa EA, Schwartzman BS, Cavalcante JS, Yagyu EM, et al. Impact of cyclosporin A pharmacokinetics on the presence of side effects in pediatric renal transplantation. J Am Soc Nephrol 2000; 11:343
-
(2000)
J Am Soc Nephrol
, vol.11
, pp. 343
-
-
David-Neto, E.1
Lemos, F.B.2
Furusawa, E.A.3
Schwartzman, B.S.4
Cavalcante, J.S.5
Yagyu, E.M.6
-
20
-
-
0029028666
-
Calcineurin activity is only partially inhibited in leukocytes of cyclosporine-treated patients
-
Batiuk TD, Pazderka F, Halloran PF. Calcineurin activity is only partially inhibited in leukocytes of cyclosporine-treated patients. Transplantation 1995; 59:1400
-
(1995)
Transplantation
, vol.59
, pp. 1400
-
-
Batiuk, T.D.1
Pazderka, F.2
Halloran, P.F.3
-
21
-
-
0030830238
-
Calcineurin activity in children with renal transplants receiving cyclosporine
-
Quien RM, Kaiser BA, Dunn SP, Kulinsky A, Polinsky M, Baluarte HJ, et al. Calcineurin activity in children with renal transplants receiving cyclosporine. Transplantation 1997; 64:1486
-
(1997)
Transplantation
, vol.64
, pp. 1486
-
-
Quien, R.M.1
Kaiser, B.A.2
Dunn, S.P.3
Kulinsky, A.4
Polinsky, M.5
Baluarte, H.J.6
-
22
-
-
0033571210
-
The temporal profile of calcineurin inhibition by cyclosporine in vivo
-
Halloran PF, Helms LM, Kung L, Noujaim J. The temporal profile of calcineurin inhibition by cyclosporine in vivo. Transplantation 1999; 68:1356
-
(1999)
Transplantation
, vol.68
, pp. 1356
-
-
Halloran, P.F.1
Helms, L.M.2
Kung, L.3
Noujaim, J.4
-
23
-
-
0037852297
-
Long term follow up of maintenance patients converted to C2 cyclosporine using Neoral immunosuppression
-
Abstract no. 925
-
Levy G, Smith R, O'Grady C, Lilly LB, Girgah N, Greig PD, Grant DR. Long term follow up of maintenance patients converted to C2 cyclosporine using Neoral immunosuppression. Abstract no. 925. Am J Transplant 2002; 2:370
-
(2002)
Am J Transplant
, vol.2
, pp. 370
-
-
Levy, G.1
Smith, R.2
O'Grady, C.3
Lilly, L.B.4
Girgah, N.5
Greig, P.D.6
Grant, D.R.7
-
24
-
-
0037774756
-
Clinical benefits of Neoral C2 monitoring in the long-term management of renal transplant recipients
-
Cole E, Maham N, Cardella C, Cattran D, Fenton S, Hamel J, et al. Clinical benefits of Neoral C2 monitoring in the long-term management of renal transplant recipients. Transplantation 2003; 75:2086
-
(2003)
Transplantation
, vol.75
, pp. 2086
-
-
Cole, E.1
Maham, N.2
Cardella, C.3
Cattran, D.4
Fenton, S.5
Hamel, J.6
-
25
-
-
0034908479
-
Conversion from cyclosporin a to tacrolimus is safe and decreases blood pressure, cholesterol levels and TGF-beta 1 type I receptor expression
-
Baan CC, van Riemsdijk-van Overbeeke IC, Balk AH, Vantrimpont PM, Mol WM, Knoop CJ, et al. Conversion from cyclosporin A to tacrolimus is safe and decreases blood pressure, cholesterol levels and TGF-beta 1 type I receptor expression. Clin Transplant 2001; 15:276
-
(2001)
Clin Transplant
, vol.15
, pp. 276
-
-
Baan, C.C.1
Van Riemsdijk-van Overbeeke, I.C.2
Balk, A.H.3
Vantrimpont, P.M.4
Mol, W.M.5
Knoop, C.J.6
-
26
-
-
0034719672
-
The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol
-
Thorp M, DeMattos A, Bennett W, Barry J, Norman D. The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol. Transplantation 2000; 69:1218
-
(2000)
Transplantation
, vol.69
, pp. 1218
-
-
Thorp, M.1
DeMattos, A.2
Bennett, W.3
Barry, J.4
Norman, D.5
-
27
-
-
0031804665
-
Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus
-
Friemann S, Feuring E, Padberg W, Ernst W. Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus. Transplant Proc 1998; 30:1240
-
(1998)
Transplant Proc
, vol.30
, pp. 1240
-
-
Friemann, S.1
Feuring, E.2
Padberg, W.3
Ernst, W.4
-
28
-
-
0035959923
-
Conversion from cyclosporine to FK506 in adult liver transplant recipients: A combined North American and European experience
-
Selzner N, Durand F, Bernuau J, Heneghan MA, Tuttle-Newhall JE, Belghiti J, et al. Conversion from cyclosporine to FK506 in adult liver transplant recipients: a combined North American and European experience. Transplantation 2001; 72:1061
-
(2001)
Transplantation
, vol.72
, pp. 1061
-
-
Selzner, N.1
Durand, F.2
Bernuau, J.3
Heneghan, M.A.4
Tuttle-Newhall, J.E.5
Belghiti, J.6
-
29
-
-
0033774719
-
A meta-analysis of immunosuppression withdrawal trials in renal transplantation
-
Kasiske BL, Chakkera HA, Louis TA, Ma JZ. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 2000; 11:1910
-
(2000)
J Am Soc Nephrol
, vol.11
, pp. 1910
-
-
Kasiske, B.L.1
Chakkera, H.A.2
Louis, T.A.3
Ma, J.Z.4
|